C-peptide exerts beneficial effects on myocardial blood flow and function in patients with type 1 diabetes

Diabetes

Volumn 51, Issue 10, 2002, Pages 3077-3082

  Hansen, Alexander ^a   Johansson, Bo Lennart ^a   Wahren, John ^a   Von Bibra, Helene ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; DIPYRIDAMOLE; SODIUM CHLORIDE;

ADULT; ARTICLE; BLOOD VOLUME; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTRAST ECHOCARDIOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLE; DOPPLER ECHOCARDIOGRAPHY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; HEART FUNCTION; HEART MUSCLE BLOOD FLOW; HEART MUSCLE PERFUSION; HEMODYNAMICS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLE;

EID: 0036787388     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.10.3077     Document Type: Article

References (39)

1. Johansson BL, Kernell A, Sjöberg S, Wahren J: Influence of combined C-peptide and insulin administration on renal function and metabolic control in diabetes type 1. J Clin Endocrinol Metab 77:976-981, 1993
2. Johansson BL, Borg K, Fernqvist-Forbes E, Odergren T, Remahl S, Wahren J: C-peptide improves autonomic nerve function in IDDM patients. Diabetologia 39:687-695, 1996
3. Johansson BL, Linde B, Wahren J: Effects of C-peptide on blood flow, capillary diffusion capacity and glucose utilization in the exercising forearm of type 1 (insulin-dependent) diabetic patients. Diabetologia 35:1151-1158, 1992
4. Jensen J, Messina E: C-peptide induces a concentration-dependent dilatation of skeletal muscle arterioles only in presence of insulin. Am J Physiol 276:H1223-H1228, 1999
5. Ekberg K, Johansson B-L, Wahren J: Stimulation of bloodflow by C-peptide in patients with type 1 diabetes. Diabetologia 44 (Suppl. 1):A323, 2001
6. Pitkaenen OP, Nuutila P, Raitakari OT, Roennemaa T, Koskinen PJ, Iida H, Lehtimaeki TJ, Laine HK, Takala T, Viikari JSA, Knuuti J: Coronary flow reserve is reduced in young men with IDDM. Diabetes 47:248-254, 1998
7. Mildenberger RR, Barschlomo BA, Druck MN: Clinically unrecognized ventricular dysfunction in young diabetic patients. J Am Coll Cardiol 4:234-238, 1984
8. Astorri E, Fiorina P, Contini GA, Albertini D, Magnati G, Astorri A, Lanfredini M: Isolated and preclinical impairment of left ventricular filling in insulin-dependent and non-insulin-dependent diabetic patients. Clin Card 20:536-540, 1997
9. Wei K, Jayaweera AR, Firoozan S, Linka A, Skyba DM, Kaul S: Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation 97:795-799, 1998
10. von Bibra H, Bone D, Niklasson U, Eurenius L, Hansen A: Myocardial contrast echocardiography yields best accuracy using quantitative analysis of digital data from pulse inversion technique: comparison with second harmonic imaging and harmonic power Doppler during simultaneous SPECT studies. Eur J Echocardiography. In press
11. Porter TR, Xie F, Silver M, Kricsfeld D, O'Leasry E: Real-time perfusion imaging withlow mechanical index pulse inversion Doppler imaging. J Am Coll Cardiol 37:748-753, 2001
12. Wei K, Ragosta M, Thorpe J, Coggins M, Moos S, Kaul S: Noninvasive quantification of coronary blood flow reserve in humans using myocardial contrast echocardiography. Circulation 103:2560-2565, 2001
13. Gorcsan J, Deswal A, Mankad S, Mandarino WA, Mahler CM, Yamazaki N, Katz WE: Quantification of the myocardial response to low-dose dobutamine using tissue Doppler echocardiographic measures of velocity and velocity gradient. J Am Cardiol 81:615-623, 1998
14. von Bibra H, Tuchnitz A, Klein A, Schneider J, Schoemig A, Schwaiger M: Regional diastolic function by pulsed Doppler myocardial mapping for the detection of left ventricular ischemia during pharmacological stress testing. J Am Coll Cardiol 36:444-452, 2000
15. Pelberg RA, Wei K, Kamiyama N, Sklenar J, Bin J, Kaul S: Potential advantage of flash echocardiography for digital subtraction of B-mode images acquired during myocardial contrast echocardiography. JASE 12:85-93, 1999
16. 1c by a new liquid-chromatographic assay: methodology, clinical utility, and relation to glucose tolerance evaluated. Clin Chem 32:1867-1872, 1986
17. Arnqvist H, Olsson PO, von Schenk H: Free and total insulin determined after precipitation with polyethylene glycol: analytic characteristics and effects of sample handlings and storage. Clin Chem 33:93-96, 1987
18. Zarich S, Arbuckle B, Cohen L, Roberts M, Nesto R: Diastolic abnormalities in young asymptomatic diabetic patients assessed by pulsed Doppler echocardiography. J Am Coll Cardiol 12:114-120, 1988
19. Appleton CP, Hatle LK: The natural history of left ventricular filling abnormalities: assessment by two-dimensional and Doppler echocardiography. Echocardiography 9:438-457, 1992
20. Garcia MJ, Thomas JD, Klein AL: New Doppler echocardiographic applications for the study of diastolic function. J Am Coll Cardiol 32:865-875, 1998
21. Nagueh SF, Bachinski L, Meyer D, Hill R, Zoghbi W, Tam J, Quinones M, Roberts R, Marian A: Tissue Doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy. Circulation 104:128-130, 2001
22. Yu CM, Lin H, Yuang H, Kong SL, Zhang Q, Wai-Luen Lee S: Progression of systolic abnormalities in patients with isolated diastolic heart failure and diastolic dysfunction. Circulation 105:1195-1201, 2002
23. Gilbert JC, Glantz SA: Determinants of left ventricular filling and of the diastolic pressure-volume relation. Circulation Research 64:827-851, 1989
24. Nitenberg A, Valensi P, Sachs R, Dali M, Aptecar E, Attali J-R: Impairment of coronary vascular reserve and ACh induced coronary vasodilatation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function. Diabetes 42:1017-1025, 1993
25. Johnstone MT, Creager SJ, Scales KM, Cusco JA, Lee BK, Creager MA: Impaired endothelium dependent vasodilatation in patients with insulin dependent diabetes mellitus. Circulation 88:2510-2516, 1993
26. Sutherland CG, Fisher BM, Frier BM, Dargie HJ, More IA, Lindop GB: Endomyocardial biopsy pathology in insulin-dependent diabetic patients with abnormal ventricular function. Histopathology 14:593-602, 1989
27. Dawson D, Vincent MA, Barrett EJ, Kaul S, Clark A, Leong-Poi H, Lindner JR: Vascular recruitment in skeletal muscle during exercise and hyperinsulinemia assessed by contrast ultrasound. Am J Physiol Endocrinol Metab 282:E714-20, 2002
28. Kassab GS, Lin DH, Fung YB: Morphometry of pig coronary venous system. Am J Physiol 267:H2100-H2113, 1994
29. Vincent MA, Dawson D, Clark A, Lindner JR, Rattigan S, Clark MG, Barrett EJ: Skeletal muscle microvascular recruitment by physiological hyperinsulinemia precedes increases in total blood flow. Diabetes 51:42-48, 2002
30. Wu CC, Feldman MD, Mills JD, Manaugh CA, Fischer D, Jafar MZ, Villanueva FS: Myocardial contrast echocardiography can be used to quantify intramyocardial blood volume: new insights into structural mechanisms of coronary autoregulation. Circulation 96:1004-1011, 1997
31. Meyer C, Schwaiger M: Myocardial blood flow and glucose metabolism in diabetes mellitus. Am J Cardiol 80:94A-101A, 1997
32. Cleland SJ, Petrie JR, Ueda S, Elliott HL, Connell JMC: Insulin as a vascular hormone: implications for the pathophysiology of cardiovascular disesase. Clin Exp Pharmacol Physiol 25:175-184, 1998
33. Fernqvist-Forbes E, Johansson B-L, Eriksson M: Effects of C-peptide on forearm blood flow and brachial artery dilatation in patients with type 1 diabetes. Acta Physiol Scand 172:159-165, 2001
34. Forst T, Kunt T, Pohlmann T, Goitom K, Engelbach M, Beyer J, Pfuetzner A: Biological activity of C-peptide on the skin microcirculation in patients with insulin dependent diabetes mellitus. J Clin Invest 101:2036-2041, 1998
35. Johansson B-L, Sjöberg S, Wahren J: The influence of human C-peptide on renal function and glucose utilization in type 1 (insulin-dependent) diabetic patients. Diabetologia 35:121-128, 1992
36. Cotter MA, Cameron NE: The effect of insulin C-peptide on nerve function in diabetic rats are blocked by nitric oxide synthase inhibition (Abstract). Diabetologia 44 (Suppl. 1):A46, 2001
37. Forst T, Kunt T, Pohlmann T, Goitom K, Schneider S, Löbig M, Engelbach M, Beyer J, Pfützner A: Proinsulin C-peptide increase plasma c-GPM levels in the endothelium-dependent microvascular response in type 1 diabetic patients (Abstract). Diabetes 48 (Suppl. 1):A201, 1999
38. +-ATPase activity in synergism with neuropeptide Y. Diabetologia 39:199-205, 1996
39. Lawson ML, Gerstein HC, Tsui E, Zinman B: Effect of intensive insulin therapy on early macrovascular disease in young individuals with type 1 diabetes: a systematic review and meta-analysis. Diabetes Care 22 (Suppl. 2):B35-B39, 1999